ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790 | +6.5% | 28,200 | +19.0% | 0.00% | 0.0% |
| Q2 2023 | $742 | +30.4% | 23,700 | +17.3% | 0.00% | +33.3% |
| Q1 2023 | $569 | +7.8% | 20,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $528 | -99.9% | 20,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $451,000 | -25.1% | 20,200 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $602,000 | +11.1% | 20,200 | -1.9% | 0.00% | +33.3% |
| Q1 2022 | $542,000 | -27.4% | 20,600 | -35.8% | 0.00% | -25.0% |
| Q4 2021 | $747,000 | -33.7% | 32,100 | -12.1% | 0.00% | -33.3% |
| Q3 2021 | $1,126,000 | +25.8% | 36,500 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $895,000 | +57.6% | 36,500 | +20.1% | 0.01% | +66.7% |
| Q1 2021 | $568,000 | -6.3% | 30,400 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $606,000 | +20.2% | 30,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $504,000 | +7.7% | 30,400 | +26.1% | 0.00% | +100.0% |
| Q2 2020 | $468,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |